Phagenyx® is the first and only clinically validated neuromodulation system that utilizes pharyngeal electrical stimulation (PES) to improve swallowing safety and efficiency to accelerate recovery from post-stroke dysphagia. Supported by 30+ publications and designed for real-world care, Phagenyx enables early intervention, resulting in a 6-day faster return to oral nutrition, >2x improvement in swallowing safety, and 8 fewer days in the hospital.
| Website | http://www.phagenesis.com |
| Revenue | $7.3 million |
| Employees | 83 (60 on RocketReach) |
| Founded | 2007 |
| Phone | +44 161 820 4525 |
| Fax | +44 161 820 4529 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Retail, Medical Devices, Biotechnology, Dysphagia treatment, Science and Engineering, Stroke rehabilitation, Health Care, Medical |
| Web Rank | 9 Million |
| Keywords | Dysphagia Treatment, Rehabilitation Technology, Swallowing Disorders, Swallowing Assessment, Speech Therapy, Respiratory Care, Eating Disorders, Patient Care, Medical Devices, Healthcare Technology, Oropharyngeal Dysphagia, Health Technology, Medical Technology, Therapeutic Devices |
| Competitors | Medtronic, Boston Scientific, Stryker, Johnson & Johnson, Abbott, Cochlear, CIVITAS SOLUTIONS INC, CONMED Corporation, Zimmer Biomet, AngioDynamics +32 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Phagenesis Ltd employee's phone or email?
The Phagenesis Ltd annual revenue was $7.3 million in 2026.
Conor Mulrooney is the COO of Phagenesis Ltd.
60 people are employed at Phagenesis Ltd.
The NAICS codes for Phagenesis Ltd are [33, 339].
The SIC codes for Phagenesis Ltd are [38, 384].